High-performance lung-targeted bio-responsive platform for severe colistin-resistant bacterial pneumonia therapy.

Authors:
Cheng D; Tian R; Pan T; Yu Q; Wei L and 6 more

Journal:
Bioact Mater

Publication Year: 2024

DOI:
10.1016/j.bioactmat.2024.02.017

PMCID:
PMC10885821

PMID:
38404643

Journal Information

Full Title: Bioact Mater

Abbreviation: Bioact Mater

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Materials Science, Biomaterials

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest None."

Evidence found in paper:

"Funding This study was supported by the Natural Science Foundation of Shanghai [grant number 23ZR1456800], the Interdisciplinary Program of 10.13039/501100004921Shanghai Jiao Tong University [grant number YG2021ZD07], the 10.13039/501100003399Science and Technology Commission of Shanghai Municipality [grant number 20Y11901100], the Clinical Science and Technology Innovation Project of SHCD [grant number SHDC22021212], the 10.13039/501100001809National Natural Science Foundation of China [grant number 82002188], the Scientific Research Project Plan of Shanghai Municipal Health Commission [grant number 20204Y0145], and the Guangci Discipline Group Construction of Public Health and Disaster Emergency Center [grant number XKQ-09]."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025